Spyre Therapeutics, Inc. (SYRE)
33.73
+0.49
(+1.47%)
USD |
NASDAQ |
Jan 20, 16:00
33.74
+0.02
(+0.04%)
After-Hours: 20:00
Spyre Therapeutics Market Cap: 2.617B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| PTC Therapeutics, Inc. | 5.867B |
| NovaBay Pharmaceuticals, Inc. | 820.13M |
| Palatin Technologies, Inc. | 15.63M |
| Theriva Biologics, Inc. | 6.107M |
| Oragenics, Inc. | 0.7982M |
Market Cap Related Metrics
| Price to Book Value | 5.751 |
| Price | 33.73 |
| Earnings Yield | -6.46% |